References
- Khan MA. Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Slomen JS, Weinblatt ME, Weisman MH, Editors. Rheumatolgy, 3rd ed. London, UK: Mosby; 2003: 1161-1181.
- Rémy M, Bouillet P, Bertin P, Leblanche AF, Bonnet C, Pascaud JL, et al. Evaluation of magnetic resonance imaging for the detection of sacroiliitis in patients with early seronegative spondylarthropathy. Rev Rhum Engl Ed. 1996; 63(9): 577-583.
- Zochling J, Smith EU. Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol. 2010; 24(6): 747-756.
- Zhang L, Zhang YJ, Chen J, Huang XL, Fang GS, Yang LJ, et al. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: A systematic review. Microb Pathog. 2018; 117:49-54.
- Akassou A, Bakri Y. Does HLA-B27 Status influence ankylosing spondylitis phenotype? Clin Med Insights Arthritis Musculoskelet Disord. 2018; 11: 117954411775 1627.
- Mahmoudi M, Aslani S, Nicknam MH, Karami J, Jamshidi AR. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Mod Rheumatol. 2017; 27(2): 198-209.
- Wellcome Trust Case Control Consortium; Australo-Anglo American Spondylitis Consortium (TASC); Burton PR, Clayton DG, Cardon LR, Craddock N, Deloucas P, Duncanson A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007; 39(11): 1329-1337.
- Ni Y, Jiang C. Identification of potential target genes for ankylosing spondylitis treatment. Medicine (Baltimore) 2018; 97(8): e9760.
- Alberts B, Johnson A, Lewis J, Morgan D, Raff M, Roberts K, et al. Control of gene expression. In: Bird A, Brockdorff N, Guthrie C, Lee J, Levine M, Madhani H, Editors. Molecular Biology of the Cell, 6th ed. New York, NY, USA: Galrland Science, Taylor & Francis Group, 2015: 429-431.
- Jiang Y, Wang L. Role of histone deacetylase 3 in ankylosing spondylitis via negative feedback loop with microRNA-130a and enhancement of tumor necrosis factor-1α expression in peripheral blood mononuclear cells. Mol Med Rep. 2016; 13(1): 35-40.
- Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol. 2013; 173(1): 47-57.
- Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994; 21(12): 2286-2291.
- Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994; 21(12): 2281-2285.
- Ricci-Vitiani L, Vacca A, Potolicchio I, Scarpa R, Bitti P, Sebastiani G, et al. MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia. J Rheumatol. 2000; 27(9): 2193-2197.
- Beltz GT. miR-142 keeps CD4+ DCs in balance. Blood. 2013; 121(6): 871-872.
- Sun Y, Sun J, Tomomi T, Nieves E, Mathewson N, Tamaki H, et al. PU. 1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J Immunol. 2013; 190(8): 4005-4013.
- Talebi F, Ghorbani S, Chan WF, Boghozian R, Masoumi F, Ghasemi S, et al. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. J Neuroinflammation. 2017; 14(1): 55.
- Duijvis NW, Moerland PD, Kunne C, Slaman MMW, van Dooren FH, Vogels EW, et al. Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis. PLoS One. 2017; 12(10): e0185097.
- Teng Z, Xie X, Zhu Y, Liu J, Hu X, Na Q, et al. miR-142-5p in Bone marrow-derived mesenchymal stem cells promotes osteoporosis involving targeting adhesion molecule VCAM-1 and inhibiting cell migration. Biomed Res Int. 2018; 2018: 3274641. doi: 10.1155/2018/3274641. eCollection 2018.
- Lin XT, Zheng XB, Fan DJ, Yao QQ, Hu JC, Lian L, et al. MicroRNA-143 targets ATG2B to inhibit autophagy and increase inflammatory responses in Crohn’s disease. Inflamm Bowel Dis. 2018; 24(4): 781-791.
- Hong BK, You S, Yoo SA, Park D, Hwang D, Cho CS, et al. MicroRNA-143 and 145 modulate the phenotype of synovial fibroblasts in rheumatoid arthritis. Exp Mol Med. 2017; 49(8): e363.